Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$405M |
| 2 |
Gilead Sciences
GILD
|
+$314M |
| 3 |
Union Pacific
UNP
|
+$229M |
| 4 |
Intel
INTC
|
+$224M |
| 5 |
Meta Platforms (Facebook)
META
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$342M |
| 2 |
SWY
SAFEWAY INC
SWY
|
+$210M |
| 3 |
TSMC
TSM
|
+$174M |
| 4 |
GSK
GSK
|
+$156M |
| 5 |
Johnson & Johnson
JNJ
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.05% |
| 2 | Technology | 11.94% |
| 3 | Consumer Discretionary | 11.2% |
| 4 | Industrials | 10.96% |
| 5 | Consumer Staples | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
NXP Semiconductors
NXPI
$67.6B
| $51.6M | 0.11% |
514,000
-26,891
| -5% | -$2.37M |
|
202
Markel Group
MKL
$25.2B
| $51.6M | 0.11% |
67,081
-10,477
| -14% | -$7.57M |
|
203
SEI Investments
SEIC
$12.2B
| $51.5M | 0.11% |
1,168,726
-527,000
| -31% | -$22.1M |
|
204
Bank of Montreal
BMO
$125B
| $51.3M | 0.11% |
855,095
+461,800
| +117% | +$28.6M |
|
|
VG
205
DELISTED
Vonage Holdings Corporation
VG
| $51.1M | 0.11% |
10,405,026
+762,300
| +8% | +$3.4M |
|
|
PX
206
DELISTED
Praxair Inc
PX
| $50.9M | 0.11% |
+421,906
| New | +$52.8M |
|
|
DRC
207
DELISTED
DRESSER-RAND GROUP INC
DRC
| $50.8M | 0.11% |
+632,570
| New | +$51.2M |
|
208
Pilgrim's Pride
PPC
$6.94B
| $50.8M | 0.11% |
2,249,500
-687,213
| -23% | -$19.5M |
|
|
PRE
209
DELISTED
PARTNERRE LTD
PRE
| $50.8M | 0.11% |
444,200
+197,000
| +80% | +$22.6M |
|
210
CenterPoint Energy
CNP
$28.8B
| $50.6M | 0.11% |
2,479,200
+491,200
| +25% | +$10.7M |
|
|
SWI
211
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $49.9M | 0.11% |
974,100
+395,500
| +68% | +$19.6M |
|
212
Chubb
CB
$139B
| $49.8M | 0.11% |
+447,100
| New | +$50.3M |
|
|
HOLX
213
DELISTED
Hologic
HOLX
| $49.6M | 0.11% |
1,501,318
-759,300
| -34% | -$23.3M |
|
214
Core Laboratories
CLB
$518M
| $49.3M | 0.1% |
471,500
+325,500
| +223% | +$34.7M |
|
215
Carter's
CRI
$1.43B
| $49.1M | 0.1% |
531,400
+231,200
| +77% | +$20M |
|
216
RH
RH
$3.4B
| $49.1M | 0.1% |
495,300
+304,100
| +159% | +$27.6M |
|
|
CELG
217
DELISTED
Celgene Corp
CELG
| $49.1M | 0.1% |
+425,600
| New | +$50.9M |
|
218
FirstEnergy
FE
$28.5B
| $49.1M | 0.1% |
1,399,100
+159,300
| +13% | +$5.96M |
|
219
Stanley Black & Decker
SWK
$14.6B
| $49M | 0.1% |
513,662
+160,327
| +45% | +$15.3M |
|
220
SiriusXM
SIRI
$10.5B
| $48.5M | 0.1% |
1,269,010
+484,900
| +62% | +$18.2M |
|
221
Annaly Capital Management
NLY
$16.9B
| $48.4M | 0.1% |
1,163,175
+621,975
| +115% | +$26.4M |
|
222
Ovintiv
OVV
$16.6B
| $48.1M | 0.1% |
862,640
-14,020
| -2% | -$882K |
|
|
HES
223
DELISTED
Hess
HES
| $48M | 0.1% |
706,663
+91,000
| +15% | +$6.49M |
|
224
Cal-Maine
CALM
$4.2B
| $47.9M | 0.1% |
1,227,308
-26,300
| -2% | -$972K |
|
225
Molina Healthcare
MOH
$10.4B
| $47.8M | 0.1% |
710,350
+527,200
| +288% | +$30.5M |
|
Similar funds
Renaissance Technologies's Q1 2015 Portfolio in Review
As of Q1 2015, Renaissance Technologies held 3,575 positions worth $47B, up 13% from $41.4B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
Renaissance Technologies deployed $4.23B of net new capital in Q1 2015, opening 633 new positions and adding to 1,637 existing holdings. Its largest new stake was Amazon: 23,057,100 shares worth $429M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was McDonald's, an estimated $342M trimmed.
- Renaissance Technologies's largest Q1 2015 buy was Amazon: 23,057,100 shares worth $429M.
- Renaissance Technologies added most to Gilead Sciences in Q1 2015, an estimated $314M increase.
- Renaissance Technologies's biggest Q1 2015 reduction was McDonald's, cutting an estimated $342M.
- Renaissance Technologies fully exited SAFEWAY INC in Q1 2015, selling an estimated $210M.
- Renaissance Technologies's ten largest holdings make up 9.9% of its $47B portfolio in Q1 2015.
- Renaissance Technologies opened 633 new positions and closed 438 in Q1 2015.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $47B.
Based on Renaissance Technologies's 13F filing for Q1 2015, filed 13 May 2015.